Matches in Wikidata for { <http://www.wikidata.org/entity/Q64140051> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64140051 description "clinical trial" @default.
- Q64140051 description "ensayu clínicu" @default.
- Q64140051 description "klinisch onderzoek" @default.
- Q64140051 description "клінічне випробування" @default.
- Q64140051 name "Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)" @default.
- Q64140051 type Item @default.
- Q64140051 label "Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)" @default.
- Q64140051 prefLabel "Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)" @default.
- Q64140051 P1050 Q64140051-B813D89B-74BF-4000-A6FA-2995C459F9B1 @default.
- Q64140051 P1132 Q64140051-625040E3-B05D-4B6D-BFF7-6C32E3C50F16 @default.
- Q64140051 P131 Q64140051-C536A372-FA69-4EF7-A23E-AEB55043EAF7 @default.
- Q64140051 P1476 Q64140051-7C6B5753-F9D5-49B0-856B-53F34A9D752E @default.
- Q64140051 P17 Q64140051-3C1F2AE0-E9C2-4021-A648-C229A34C327F @default.
- Q64140051 P17 Q64140051-4370D61A-C8AD-4E7A-8EA2-0CA7D89AA88B @default.
- Q64140051 P17 Q64140051-49256509-016A-46B4-86A3-980E722642C1 @default.
- Q64140051 P17 Q64140051-B67B5234-09E4-4980-8288-252EDD11D7CC @default.
- Q64140051 P1813 Q64140051-DA132300-8E3D-4731-9E82-79C3842FBB02 @default.
- Q64140051 P2899 Q64140051-1F4B7098-F41F-4193-B619-844C728226E2 @default.
- Q64140051 P3098 Q64140051-C0BDAF3E-7812-4D41-B232-44C5A89D528F @default.
- Q64140051 P31 Q64140051-E8F70F2B-B4E3-4984-BAD5-619197832E0A @default.
- Q64140051 P4844 Q64140051-0AECC4B6-4095-4734-A5D1-11B6B15C56C4 @default.
- Q64140051 P580 Q64140051-479FA681-8530-4244-8969-15A7BB7D8C5C @default.
- Q64140051 P582 Q64140051-274626ED-ED89-4A9B-BACF-AC8112471576 @default.
- Q64140051 P6099 Q64140051-E53B2E1A-54D0-43D3-8349-DDAB739CC357 @default.
- Q64140051 P6153 Q64140051-154890FA-3DBF-40FD-86F1-2760F6F3D36E @default.
- Q64140051 P8363 Q64140051-BA6FD42F-164C-4B97-B881-7C384CB5E926 @default.
- Q64140051 P1050 Q12206 @default.
- Q64140051 P1132 "+868" @default.
- Q64140051 P131 Q8646 @default.
- Q64140051 P1476 "Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes. A 30-week Randomised, Double-blind, Double-dummy, Active-controlled, Parallel-group, Multi-centre and Multi-national Trial" @default.
- Q64140051 P17 Q155 @default.
- Q64140051 P17 Q212 @default.
- Q64140051 P17 Q258 @default.
- Q64140051 P17 Q865 @default.
- Q64140051 P1813 "SUSTAIN" @default.
- Q64140051 P2899 "+18" @default.
- Q64140051 P3098 "NCT03061214" @default.
- Q64140051 P31 Q30612 @default.
- Q64140051 P4844 Q19484 @default.
- Q64140051 P580 "2017-08-28T00:00:00Z" @default.
- Q64140051 P582 "2019-03-14T00:00:00Z" @default.
- Q64140051 P6099 Q42824827 @default.
- Q64140051 P6153 Q818846 @default.
- Q64140051 P8363 Q78089383 @default.